News

Zacks Small Cap Research on MSN19d
TELO Reverses Damage in Progeria Cells
TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to reverse biological aging and ...
Miami Herald19d
Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria - an Ultra-Rare Genetic Disorder that Causes Rapid Aging - Miami Herald
The only FDA-approved therapy for progeria, Zokinvy® (lonafarnib), is a farnesyltransferase inhibitor that has been shown to extend lifespan by an average of 4.3 years. However, Zokinvy does not ...
Benzinga.com19d
EXCLUSIVE: Telomir Pharmaceuticals Says Preclinical Drug Candidate Prevents Premature Aging In Patient-Derived Cells From Children With Progeria
Telomir-1 improved survival in progeria cells and normalized ROS levels under oxidative stress. The candidate reduced mitochondrial calcium overload, restoring cell energy balance. From tariffs to ...